Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant

NCT00810602 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancies
Graft vs Host Disease

Interventions

PROCEDURE: reduced intensity, related donor stem cell transplant
DRUG: tacrolimus (standard GVHD prophylaxis)
DRUG: mycophenolate (standard GVHD prophylaxis)
DRUG: vorinostat

Sponsor

Pavan Reddy, MD